title: Diabetes complications: the microRNA perspective.
authors.affiliation: Diabetes Division, Juvenile Diabetes Research Foundation Danielle Alberti Memorial Centre for Diabetes Complications, Baker IDI Heart and Diabetes Institute, Melbourne, Australia. phillip.kantharidis@bakeridi.edu.au
authors.forename: Phillip
authors.initials: P
authors.lastname: Kantharidis
authors.forename: Bo
authors.initials: B
authors.lastname: Wang
authors.forename: Rosemarie M
authors.initials: RM
authors.lastname: Carew
authors.forename: Hui Yao
authors.initials: HY
authors.lastname: Lan
mesh_terms: D000818:Animals; D009202:Cardiomyopathies / Q000209:etiology; D048909:Diabetes Complications / Q000235:genetics / Q000503:physiopathology*; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics; D003928:Diabetic Nephropathies / Q000209:etiology / Q000235:genetics; D003930:Diabetic Retinopathy / Q000209:etiology; D006801:Humans; D035683:MicroRNAs / Q000502:physiology*; D009206:Myocardium / Q000378:metabolism; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic / Q000502:physiology
chemical_list: C549446:MIRN133 microRNA, rat; C546783:MIRN192 microRNA, human; C524940:MIRN21 microRNA, human; D035683:MicroRNAs; C539618:Mirn192 microRNA, mouse; C543719:Mirn200 microRNA, mouse; C534064:Mirn377 microRNA, mouse; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic